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Usefulness of Seminested Polymerase
Chain Reaction for Screening Blood
Donors at Risk for Malaria in Spain
To the Editor: Assurance of blood safety relies on effec-
tive public health surveillance for infectious diseases. Appro-
priate management of emerging disease threats requires
that this surveillance be combined with screening measures
to eliminate or minimize the risk of transmitting transfu-
sion-associated disease. Diseases with a long and relatively
asymptomatic period (malaria) during which microorgan-
isms are present in the blood are of particular concern for
transfusion safety. 
Many reports have shown that falciparum malaria can 
remain in the bloodstream for a long time (even years) as an 
asymptomatic infection (1). Parasitic contamination of 
donated blood can occur only if the donor has parasitemia, 
usually asymptomatic, at the time the blood is collected.
In accordance with legislation of the European Commu-
nity and the United States, travelers who have visited 
malaria-endemic areas may be accepted as regular blood 
donors 6 months after return to the nonendemic area, pro-
viding they have been free of unexplained febrile illnesses 
and have not taken antimalarial drugs (2,3). Immigrants or 
visitors from endemic areas may donate blood 3 years after 
they leave the area if they have been asymptomatic in the 
interim. Donations to be used for the preparation of plasma, 
plasma components, or derivatives devoid of intact erythro-
cytes are exempt from these restrictions.
Transfusion-associated cases of malaria have occurred 
in recent years in the European Community and the United 
States, although the residual risk of receiving a unit of 
erythrocyte concentrate contaminated with malaria para-
sites is very low (estimated at 1 case per 4 million units 
donated) (4). On the other hand, the potential survival of the 
organism in an infectious form during blood processing and 
storage should also be investigated. Several reports concur 
that all Plasmodium species can remain viable in stored 
blood for at least a week (P. falciparum malaria has been 
transmitted by blood stored for 19 days) (5). 
The increase in tourism and migration has caused an 
increase in imported cases of malaria infections in returned 
travelers and immigrants from malaria-endemic areas. The 
number of immigrants from different geographic areas of the 
world is changing the demographic pattern of European 
countries, including Spain. Since the early 1990s, the birth 
rate in the migrant population has attained the same rate as 
that of the Spanish autochthonous population. This fact has 
led the migrant population to be incorporated into every 
layer of society, including the agricultural, construction, and 
health sectors. 
Moreover, the shortage of blood reserves in Spanish hos-
pitals and the increase in immigrants who donate blood indi-
cate a need for sensitive diagnostic techniques capable of 
detecting parasites in blood. Currently no tests are approved 
in Spain to screen donated blood for malaria, and careful 
questioning is essential to identify prospective donors at risk 
for transmitting malaria.
Experience in our Spanish reference laboratory indi-
cates that new laboratory tests should be implemented to 
screen high-risk donor blood, especially for malaria and Cha-
gas disease. These tests should be sensitive enough to reject 
all contaminated donations but specific enough to achieve a 
strong positive predictive value and minimize unnecessary 
deferral of otherwise acceptable donors. 
We describe the potential use of the seminested multi-
plex  malaria polymerase chain reaction (SNM-PCR) to 
screen potential blood donors at risk (immigrants from 
malaria-endemic areas) and reduce the time they are 
excluded as regular blood donors (3 years). We have reported 
that the SNM-PCR is capable of detecting 0.004 to 0.04 para-
sites per microliter of blood (6). In accordance with these 
data, we addressed the following questions: could SNM-PCR 
be a useful tool to screen prospective donors at risk? If so, 
could the 3-year deferral period be shortened for donors 
whose PCR results are negative?
To evaluate SNM-PCR in potential blood donors at risk, 
we conducted a study, approved by the Ethical Committee of 
the National Institute of Health, with blood samples from 
the Red Cross Blood Center in Madrid (Spain). Throughout 
2000, our laboratory received 125 samples (5 cm3 of whole 
blood in EDTA per sample) from blood donors at risk (56 
from Colombia, 50 from Ecuador, 3 from Cameroon, 2 from 
Peru, 2 from Iran, 2 from China, and 1 each from India, 
Papua New Guinea, Sri Lanka, Mozambique, Mexico, Sene-
gal, Costa Rica, Brazil, Kenya, and Tanzania). All donors at 
risk had recently (3 months to 1 year) immigrated to Spain.
Five samples (two from Ecuador, two Colombia, and one 
India) were positive for P. falciparum in two amplifications 
from two different blood extractions per sample. The five 
PCR-positive blood specimens were negative by microscopy 
(7) (we assumed that 400 microscopic fields are equivalent to 
1 µL of blood). Our results suggest the following: a) the 
potential of this population to transmit malaria parasites 
was confirmed (4% of blood samples were positive), justifying 
the legislation in force (2,3); and b) SNM-PCR could serve as 
the reference test for screening donor blood, which could 
increase the use of these blood donations and consequently 
shorten the deferral period for blood donors.
A. Benito and J.M. Rubio
Malaria Reference Laboratory, Parasitology Department, 
National Center for Microbiology, National Institute of 
Health “Carlos III,” 28220 Majadahonda, Madrid, Spain
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